Register | Forgot password?
Switch to Arabic
Monday, November 30 - 2009

ICLDC puts focus on impact of genetics on metabolic syndrome

  • United Arab Emirates: Tuesday, October 13 - 2009 at 11:07
  • PRESS RELEASE

Speaking at the Primary Health Congress in Abu Dhabi, Dr John Chambers, a cardiologist at Imperial College London, revealed that a combination of genes and the environment is driving the explosion of metabolic syndrome prevalence, worldwide.

Article continues below
  • Dr Maha Taysir Barakat.
    Dr Maha Taysir Barakat.
He stated that the recent exponential rise in obesity and diabetes is not a genetic shift, rather an environment shift as a direct result of lifestyle habits, and suggested that three hundred and seventy five million people are expected to suffer from diabetes, metabolic syndrome and related disorders by year 2030.

"Family studies suggest that metabolic syndrome is primarily driven by environmental influences. The crucial message is that we can easily make positive changes to the environment factors, such as obesity, physical inactivity and an unfavourable diet," Dr Chambers said.

He stressed that genetic factors also play an important role. "Increased knowledge of the genetic factors improves understanding of disease mechanisms, gives clues to new treatments and enables us to identify at-risk people," he said.

Dr Chambers referred to a new research, genome wide association that has identified 76 new genetics loci for metabolic factors.

"The genome wide association studies have long-lasting implications on the clinical approach to metabolic syndrome. It offers significant insight into the development of new clinical approaches, drugs and treatments," he said, adding that the study will help drive new treatment, as well as further clinical and drugs studies.

Dr Maha Taysir Barakat, Medical and Research Director and Consultant Endocrinologist, Imperial College London Diabetes Centre (ICLDC), added that since its inception ICLDC has remained focused on the message of diabetes prevention through healthy diet, active lifestyle and weight management.

Dr Barakat and three experts from Imperial College London are addressing eight sessions over the next two days in the Metabolic Syndrome and Associated Diseases conference in the capital.

The Primary Healthcare Exhibition & Congress aims to act as a catalyst for hospitals, healthcare centres and government agencies to make primary healthcare a high priority. The conference runs in ADNEC from October 11 to 13, 2009.
Also consider reading:
Log in to request more information

Notes and media contacts

About Imperial College London Diabetes Centre:

Imperial College London Diabetes Centre is a one-stop, state-of-the-art, out-patient facility that specialises in diabetes treatment, research, and training and public health awareness.

The purpose-built Centre is an initiative of Mubadala Healthcare, in partnership with the UK's Imperial College London. Mubadala Healthcare, a division of Mubadala Development Company, is specifically dedicated to investment in strategic, high value and economically sustainable projects that meaningfully enhance the private healthcare infrastructure of Abu Dhabi and the UAE.

The launch of ICLDC in 2006 is a testament to the vision of Mubadala Healthcare to develop projects that protect and enhance the nation's health. In the past three years, ICLDC has offered diabetes prevention, education and treatment to more than 70,000 people.

'Diabetes.Knowledge.Action', is the award-winning public health awareness campaign from ICLDC. It was launched in 2007 under the patronage of HH Shaikha Fatima bint Mubarak, in partnership with The Emirates Foundation for Philanthropy.

ICLDC is located on Abu Dhabi's Khaleej Al Arabi Street, near the exhibition centre and next to the Zayed Military Hospital. A pharmacy and cafeteria are located on the ground floor and are open to the public.

For further information, please contact:

Anu Bhatnagar,
Strategic Solutions for ICLDC
Tel: + 9714 3903018

Disclaimer:

Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com

Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.

For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions